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Macrophage Migration Inhibitory Factor Is Essential
for Eosinophil Recruitment in Allergen-Induced
Skin Inflammation
Yoko Yoshihisa1,3, Teruhiko Makino1,3, Kenji Matsunaga1, Ayumi Honda2, Osamu Norisugi1, Riichiro Abe2,
Hiroshi Shimizu2 and Tadamichi Shimizu1
Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that has an essential role in the
pathophysiology of experimental allergic inflammation. Recent findings suggest that MIF is involved in several
allergic disorders, including atopic dermatitis (AD). In this study, the role of MIF in allergic skin inflammation
was examined using a murine model of AD elicited by epicutaneous sensitization with ovalbumin (OVA). We
observed the number of skin-infiltrating eosinophils to significantly increase in OVA-sensitized MIF transgenic
(Tg) mice compared with their wild-type (WT) littermates. On the other hand, eosinophils were virtually absent
from the skin of MIF knockout (KO) mice and failed to infiltrate their skin after repeated epicutaneous
sensitization with OVA. The mRNA expression levels of eotaxin and IL-5 were significantly increased in OVA-
sensitized skin sites of MIF Tg mice, but were significantly decreased in MIF KO mice in comparison with the
levels in WT littermates. Eotaxin expression was induced by IL-4 stimulation in fibroblasts in MIF Tg mice,
but not in MIF KO mice. These findings indicate that MIF can induce eosinophil accumulation in the
skin. Therefore, the targeted inhibition of MIF might be a promising new therapeutic strategy for allergic
skin diseases.
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INTRODUCTION
Atopic dermatitis (AD) is a chronic, relapsing inflammatory
disease of the skin with significant morbidity and an adverse
impact on patient well-being (Morar et al., 2006). AD is
considered to result from a dysregulation of the normal
interactions between the environment and genes, defects in
skin barrier function, and systemic and local immunological
responses (Leung et al., 2004). The contribution of the
immune response to the pathogenesis of AD has been
attributed largely to abnormalities in adaptive immunity,
with key roles being played by T-helper 1(Th1)/Th2 cell
dysregulation, IgE production, dendritic cell signaling, and
mast-cell hyperactivity, leading to the pruritic, inflammatory
dermatosis that characterizes AD (Leung et al., 2004). In
addition, accumulation of eosinophils is characteristic of the
inflammation associated with AD (Honma et al., 2000).
Macrophage migration inhibitory factor (MIF) was the first
lymphokine reported to prevent random migration of macro-
phages (Bloom and Bennett, 1966). As the molecular cloning
of MIF complementary DNA (Weiser et al., 1989), MIF has
been re-evaluated as a proinflammatory cytokine and
pituitary-derived hormone that potentiates endotoxemia
(Bernhagen et al., 1993; Bucala, 1996). MIF has an important
role in delayed-type hypersensitivity (Bernhagen et al., 1998).
Recently, it has been demonstrated that MIF also upregulates
the expression of Toll-like receptor-4, which mediates
lipopolysaccharide binding and activation of macrophages
(Roger et al., 2001). MIF is now recognized as a cytokine that
exhibits a broad range of immune and inflammatory
activities, including induction of inflammatory cytokines,
and regulation of macrophage and lymphocyte proliferation.
Furthermore, MIF induces the endothelial expression of
E-selectin, ICAM-1, vascular cell adhesion molecule-1, IL-8,
and monocyte chemoattractant protein-1, thus resulting in
leukocyte recruitment (Gregory et al., 2004, 2006; Cheng
et al., 2010). MIF originates from multiple cellular sources
such as activated T lymphocytes, monocytes, eosinophils,
and keratinocytes (Rossi et al., 1998; Shimizu et al., 1999;
Yamaguchi et al., 2000). MIF has also been shown to
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exacerbate human allergic and inflammatory diseases, such
as asthma (Rossi et al., 1998) and acute respiratory distress
syndrome (Donnelly et al., 1997).
We recently reported excessive expression of MIF mRNA
and protein in inflammatory skin lesions and in sera from AD
patients (Shimizu et al., 1999; Shimizu, 2005). We also
showed that the serum MIF levels decrease as the clinical
features of this disease improve, thus suggesting that MIF has
a pivotal role in the inflammatory response in AD (Shimizu
et al., 1997). These studies raise the possibility that MIF is an
important component of Th2-mediated immunopathology in
general, and might therefore be relevant to chronic inflam-
matory allergic conditions.
Eosinophils may aggravate the inflammatory response in
the skin of AD patients. Spergel et al. (1998, 1999) reported a
murine model of allergic skin inflammation elicited by
epicutaneous sensitization with ovalbumin (OVA). This
model displays many of the features of human AD, including
elevated total and specific IgE, dermatitis characterized by
infiltration of the dermis by CD4þ T cells and eosinophils,
and increased local expression of mRNAs for the cytokines
IL-4, IL-5, and IFN-g. In our present study, MIF transgenic (Tg)
mice and MIF knockout (KO) mice were used to assess the
potential role of MIF in the pathogenesis of AD in this murine
model of allergic skin inflammation. We also investigated the
effects of MIF on eotaxin expression of dermal fibroblasts.
RESULTS
The expression of MIF was increased in bone marrow and skin
from MIF Tg mice
MIF Tg mice exhibited no lethal or prominent pathological
lesions in the organs examined. A northern blot analysis
revealed the MIF mRNA expression in bone marrow and skin
from MIF Tg mice to be B10 times higher than that in wild-
type (WT) mice (Figure 1a). MIF protein was also increased in
the skin from MIF Tg mice compared with that from WT
mice, as demonstrated by western blotting (Figure 1b).
OVA-sensitized skin sites of MIF Tg mice showed marked
eosinophil infiltration
To examine the role of MIF in eosinophilic infiltration, MIF Tg
and WT mice were subjected to epicutaneous OVA sensitiza-
tion. Only a few eosinophils were present in saline-sensitized
skin from MIF Tg and WT mice, while eosinophilic infiltration
of the dermis was significantly increased following epicuta-
neous sensitization with OVA. The mean number of eosino-
phils after OVA sensitization was 13.6±2.84 in MIF Tg mice,
but only 4.8±1.37 in WT mice (Po0.001; Figure 2a). Figure
2b shows the histological features of OVA-sensitized skin sites
in MIF Tg and WT mice. The epidermis was slightly thickened,
and numerous eosinophils and mononuclear cells infiltrated
the upper dermis around the vessels, in the OVA-sensitized
skin of MIF Tg mice.
Eosinophil numbers were not increased in the OVA-sensitized
skin of MIF KO mice
To further clarify the roles of MIF in eosinophilic infiltration,
MIF KO mice were subjected to epicutaneous OVA
sensitization. The mean number of eosinophils after OVA
sensitization was 2.0±0.94 in MIF KO mice, and did not
differ from that after saline sensitization. Furthermore, this
value was significantly lower than that of WT mice
(4.8±1.37, Po0.05; Figure 3a). Histological features also
confirmed only a few eosinophils to be present in the dermis
after OVA sensitization in MIF KO mice (Figure 3b).
The expression of eotaxin and Th2-type cytokines increased in
the OVA-sensitized skin of MIF Tg mice, but decreased in the
OVA-sensitized skin in MIF KO mice
We next examined the expression of mRNAs for eotaxin and
cytokines in OVA-sensitized skin specimens from MIF Tg,
MIF KO, and WT mice. The expression levels of eotaxin and
Th2-type cytokines, especially IL-5, were increased in the
OVA-sensitized skin of MIF Tg mice compared with WT
mice. However, IFN-g, a Th1-type cytokine, did not differ
between MIF Tg and WT mice. Conversely, low eotaxin
mRNA expression was observed in the OVA-sensitized skin
of MIF KO mice compared with WT mice. Similarly, the
mRNA expression of the Th2-type cytokines, including IL-4,
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Figure 1. Expression of macrophage migration inhibitory factor (MIF) in
tissues from MIF transgenic (Tg) mice. (a) Bone marrow (BM) and skin
specimens were harvested from MIF Tg and wild-type (WT) mice, and the
total RNA levels were determined by northern blot analysis as described in the
Materials and Methods. The density of MIF bands was normalized to the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signals. BM and skin
from MIF Tg mice showed anB10-fold higher level of MIF mRNA expression
than those from WT mice. (b) Western blot analysis of skin from MIF
Tg mice showed that the MIF protein level was also higher in MIF Tg mice
than in WT mice.
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IL-5, and IL-13, were low in the OVA-sensitized skin of MIF
KO mice compared with WT mice (Figure 4).
The expression and production of eotaxin in cultured fibroblasts
from MIF Tg mice and from MIF KO mice
To clarify the role of MIF in the expression of eotaxin, we
performed in vitro experiments. A previous report described
that IL-4 could dose-dependently induce the expression of
eotaxin mRNA in dermal fibroblasts from humans and mice
(Mochizuki et al., 1998). Using this protocol, we analyzed the
eotaxin expression in cultured fibroblasts fromMIF Tg, MIF KO,
and WT mice by stimulating them with IL-4. Unstimulated
fibroblasts from these mice barely expressed eotaxin mRNA.
However, fibroblasts from MIF Tg mice showed dramatically
increased eotaxin mRNA after stimulation with 5ngml1 of IL-
4 (Figure 5a). To evaluate whether there was an accompanying
change in eotaxin protein production, the amount of eotaxin in
fibroblast supernatants was also analyzed. Eotaxin proteins in
the culture supernatant of fibroblasts from MIF Tg mice were
also significantly increased compared with those from WT
mice (*Po0.005). However, fibroblasts from MIF KO mice
showed minimal expression of eotaxin mRNA even when
stimulated with 10ngml1 of IL-4. Eotaxin production in the
culture supernatant of fibroblasts from MIF KO mice was barely
detectable (Figure 5b).
Recombinant MIF restored the expression and production of
eotaxin in dermal fibroblasts from MIF KO mice
In dermal fibroblasts from WT mice, stimulation with IL-4
significantly induced the expression of eotaxin mRNA
compared with unstimulated fibroblasts (Figure 6a). Addition
of recombinant MIF significantly enhanced this increase in
eotaxin expression. This suggests that the eotaxin expression
in dermal fibroblasts from MIF Tg mice was markedly
increased by IL-4 stimulation. A significant amount of eotaxin
was also produced by combined stimulation with IL-4
(*Po0.005, **Po0.05; Figure 6b). Although the fibroblasts
from MIF KO mice showed minimal induction of eotaxin
mRNA expression in response to stimulation with IL-4, both
the expression of eotaxin mRNA and the production of
eotaxin protein were restored by addition of recombinant MIF
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Figure 2. Eosinophil infiltration into ovalbumin (OVA)-sensitized skin sites
of macrophage migration inhibitory factor (MIF) transgenic (Tg) mice.
(a) The number of eosinophils in OVA-sensitized skin sites of MIF Tg mice
was compared with the wild-type (WT) mice. Each value represents the
mean±SD (n¼ 5; *Po0.001, **Po0.0001). (b) Histological features of
OVA-sensitized skin sites in MIF Tg mice and WT mice. Scale bar for large
panels¼ 50mm; scale bar for small panels¼ 10mm; hematoxylin and eosin
section. Arrowheads point to eosinophils. The experiments were repeated
three times and similar results were obtained.
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Figure 3. Eosinophil infiltration induced in ovalbumin (OVA)-sensitized skin
sites of macrophage migration inhibitory factor (MIF) knockout (KO) mice.
(a) The number of eosinophils in OVA-sensitized skin sites of MIF KO mice
was compared with wild-type (WT) mice. Each value represents the
mean±SD (n¼ 5, *Po0.05). (b) Histological features of OVA-sensitized
skin sites in MIF KO and WT mice. Scale bar for large panels¼ 50mm;
scale bar for small panels¼ 10 mm; hematoxylin and eosin section.
Arrowheads point to eosinophils. The experiments were repeated three
times and similar results were obtained each time.
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(Figure 6a and b). The levels of eotaxin production in MIF KO
mouse fibroblasts exposed to MIF were similar to the levels in
WT fibroblasts stimulated with IL-4 (Figure 6b).
DISCUSSION
There is growing evidence that the eosinophil is an important
effecter cell in allergic inflammatory diseases, such as asthma
and AD. Accumulation of eosinophils in the skin is character-
istic of inflammation associated with AD (Leiferman,
1989; Kapp, 1995). This study explored, for the first time,
the significant increase in eosinophil infiltration in the skin of
MIF Tg mice after OVA sensitization, compared with WT
mice. However, in MIF KO mice, eosinophils failed to
infiltrate the skin after repeated epicutaneous sensitization
with OVA. Eosinophils accumulate at inflammatory sites
and release numerous mediators capable of initiating
and maintaining allergic inflammation. Yamaguchi et al.
(2000) reported eosinophils to be an important source of
MIF in allergic inflammatory diseases. The number of
eosinophils was reported to be significantly decreased in
lung tissue and in bronchoalveolar lavage fluid from MIF KO
mice after stimulation with OVA, compared with those from
WT mice (Mizue et al., 2005; Magalha˜es et al., 2007; Wang
et al., 2009). In an allergic rhinitis model, eosinophil
recruitment into the nasal submucosa was also suppressed
in MIF KO mice (Nakamaru et al., 2005). Consistent with
these findings, our current evidence indicates that MIF is
essential for the infiltration of eosinophils into the OVA-
sensitized skin.
This study also demonstrated that the expression of both
eotaxin and IL-5 is markedly increased in the OVA-sensitized
MIF
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Figure 4. Expression levels of eotaxin and Th2-type cytokines in ovalbumin
(OVA)-sensitized skin from macrophage migration inhibitory factor (MIF)
transgenic (Tg) mice and MIF knockout (KO) mice. Reverse transcriptase-
PCR analyses of eotaxin, IL-4, IL-5, IL-13, and IFN-g levels in skin sites of MIF
Tg and WT mice sensitized with OVA were performed. Eotaxin, IL-4, IL-5,
and IL-13 mRNA expression levels were increased in OVA-sensitized MIF Tg;
however, both eotaxin and Th2-type cytokines were markedly decreased in
OVA-sensitized MIF KO mice, compared with WT mice. The experiments
were repeated three times and similar results were obtained. GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
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Figure 5. IL-4 induced eotaxin expression and production by fibroblasts
from macrophage migration inhibitory factor (MIF) transgenic (Tg) and MIF
knockout (KO) mice. Fibroblasts from MIF KO, MIF Tg, and wild-type (WT)
mice were stimulated with IL-4 (5 or 10 ngml1) for 24 hours. (a) RNA
was extracted from the cells and the abundance of eotaxin mRNA was
evaluated by reverse transcriptase-PCR. Data are from a representative
experiment that was repeated three times and yielded similar results.
(b) The eotaxin content of cultured supernatants was analyzed for eotaxin
by ELISA. Each value represents the mean±SD of five specimens.
*Po0.005, **Po0.05. ND, not detected.
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Figure 6. Recombinant macrophage migration inhibitory factor (MIF)
restored eotaxin expression and production by IL-4 stimulation in dermal
fibroblasts from MIF knockout (KO) mice. The fibroblasts were stimulated
with IL-4 (10 ngml1), MIF (100 ngml1), or both IL-4 and MIF for 24 hours.
(a) RNA was extracted from cells, and the abundance of eotaxin mRNA was
evaluated by reverse transcriptase-PCR. Data are from a representative
experiment that was repeated three times showing similar results. (b) The
eotaxin contents of cultured supernatants were analyzed for eotaxin by ELISA.
Each value represents the mean±SD of six specimens. *Po0.005, **Po0.05.
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ND, not detected.
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skin sites of MIF Tg mice skin. The other Th2-type cytokines,
IL-4 and IL-13, were also slightly increased in MIF Tg mice.
On the other hand, the expression levels of eotaxin and Th2-
type cytokines were markedly decreased in the OVA-
sensitized skin sites of MIF KO mice. Acute AD involves a
systemic Th2 response with eosinophilia, and marked
infiltration of Th2 cells into skin lesions. These infiltrating
T cells predominantly express IL-4, IL-5, and IL-13. Further-
more, the roles of cytokines in the induction of migration
and the accumulation of eosinophils into an inflamed tissue
have been extensively studied in recent years. Some of the
important eosinophil chemoattractant cytokines include IL-5,
IL-8, eotaxin, RANTES (regulated on activation, normal T cell
expressed and secreted), and monocyte chemoattractant
protein-3 (Lampinen et al., 2004). Among these, eotaxin
(CC chemokine ligand-11) is one of the most important
eosinophil-selective chemoattractants (Jose et al., 1994;
Garcia-Zepeda et al., 1996). Eotaxin is secreted by several
cell types: epithelial cells, fibroblasts, and activated infiltrat-
ing leukocytes such as eosinophils (Garcia-Zepeda et al.,
1996; Ponath et al., 1996; Uguccioni et al., 1996). Eotaxin is
reportedly related to the eosinophilia in allergic diseases,
including AD and asthma (Ying et al., 1997; Yawalkar et al.,
1999). IL-5 also has an important role in eosinophil
development and differentiation (Sanderson, 1992). IL-5 KO
mice had virtually no eosinophils in either saline-sensitized
skin or in OVA-sensitized skin (Spergel et al., 1999).
Recently, Magalha˜es et al. (2009) reported that MIF was
involved in IL-5-driven maturation of eosinophils and in
tissue eosinophilia associated with Schistosoma mansoni
infection. In addition, several earlier studies demonstrated
that MIF KO mice failed to develop tissue eosinophilia, and
that eotaxin, IL-4, and IL-5 were not induced in either allergic
lung tissues or bronchoalveolar lavage fluid (Mizue et al.,
2005; Wang et al., 2006). Accordingly, our results suggest
that MIF is important in regulating both eotaxin and IL-5 in
OVA-sensitized inflamed skin tissue.
In support of these in vivo observations, this study
demonstrated that the expression of eotaxin was significantly
increased after stimulation with IL-4 in fibroblasts from MIF
Tg mice compared with WT fibroblasts, but not in fibroblasts
from MIF KO mice. However, eotaxin expression in
fibroblasts from MIF KO mice was restored by addition of
recombinant MIF. These observations suggest that MIF is
crucial to the expression of eotaxin, and antigen-induced
eosinophil infiltration is suspected to be induced by eotaxin
mainly by MIF, in addition with IL-5 production involved in
MIF. Previous observations have shown that either IL-4 or
IL-13 can increase eotaxin expression, and that they function
synergistically with proinflammatory cytokines, such as
tumor necrosis factor-a, to increase the production of eotaxin
in epithelial cells and fibroblasts (Mochizuki et al., 1998;
Nakamura et al., 1998; Li et al., 1999; Stellato et al., 1999;
Fujisawa et al., 2000; Terada et al., 2000). Increases in both
IL-4 and IL-13 in the inflamed skin of MIF Tg mice might
involve enhancing the tissue eosinophilia. Furthermore,
tumor necrosis factor-a secretion induced by MIF also has
the ability to increase eotaxin expression in MIF Tg mice, on
the basis of the known capacity of MIF to trigger the
secretion of several inflammatory cytokines, including tumor
necrosis factor-a (Donnelly et al., 1997). It was recently
elucidated that MIF activates an extracellular signal-regulated
kinase-1/2–mitogen-activated protein kinase signaling
through its receptor CD74 (Leng et al., 2003) and c-Jun N-
terminus kinase–mitogen-activated protein kinase signaling
through CD74/CXCR4 (Lue et al., 2011), in addition to the
endocytic pathway described previously (Kleemann et al.,
2000); however, the receptor-mediated mechanism involved
in MIF-mediated IL-4-induced eotaxin release is unclear. This
mechanism should therefore be an important focus of
research in association with MIF-mediated skin allergy.
Finally, we suggest that the inhibition of MIF might be an
effective treatment for AD, suppressing both eosinophil
infiltration and eotaxin expression in the skin. We recently
demonstrated that in murine models of AD, MIF–DNA
vaccination elicited the production of endogenous anti-MIF
antibodies, producing rapid improvement of AD skin
manifestations (Hamasaka et al., 2009). Our previous data
and the current findings therefore hold promise for the
development of MIF inhibitors as a therapeutic strategy for
allergic diseases.
MATERIALS AND METHODS
Materials
The following materials were obtained from commercial sources: a
mouse eotaxin-specific ELISA kit from Genzyme TECHNE
(Cambridge, MT); Isogen RNA extraction kit from Nippon Gene
(Tokyo, Japan); M-MLV reverse transcriptase from GIBCO (Grand
Island, NY); Taq DNA polymerase from Perkin-Elmer (Norwalk, CO);
nylon membranes from Schleicher & Schuell (Keene, NH); Ficoll-
Plaque Plus and Protein A Sepharose from Pharmacia (Uppsala,
Sweden); recombinant mouse IL-4 from R&D systems (Minneapolis,
MN). Recombinant rat MIF (this recombinant MIF crossreacts with
that of mice) was expressed in Escherichia coli BL21/DE3 (Novagen,
Madison, WI) and was purified as described previously (Shimizu
et al., 2004). All other chemicals were of analytical grade.
Mice
The MIF-overexpressing Tg mice were established after complemen-
tary DNA microinjection. Physical and biochemical characteristics,
including body weight, blood pressure, and serum cholesterol and
blood sugar levels, were normal, as reported previously (Sasaki et al.,
2004). The transgene expression was regulated by a hybrid promoter
composed of the cytomegalovirus enhancer and the b-actin/b-globin
promoter, as reported previously (Akagi et al., 1997). The strain of
the original MIF Tg mice was ICR, which were backcrossed with
C57BL/6 for at least 10 generations. Tg mice were maintained by
heterozygous sibling mating. Aged MIF Tg mice of 12 months or
older developed neither skin allergies nor diseases. The MIF-
deficient (KO) mice were established by targeted disruption of the
MIF gene as described previously (Honma et al., 2000), using a
mouse strain bred onto a C57BL/6 background. MIF Tg, MIF KO, and
WT mice were maintained under specific-pathogen-free conditions
at the Institute for Animal Experiments of the Graduate School of
Medicine and Pharmaceutical Sciences, University of Toyama. All
experiments were performed on 8-week-old female adult mice.
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Epicutaneous sensitization
Epicutaneous sensitization of mice was performed as described
previously (Spergel et al., 1998). Briefly, each mouse was
anesthetized with 10% nembutal (Hospira, Osaka, Japan), then
shaved with a razor. One hundred mg of OVA (Sigma, St Louis, MO)
in 100ml of normal saline were placed on a 1 1 cm patch
(Alcare, Tokyo, Japan), which was secured to the skin with a
transparent bio-occlusive dressing (ALCARE). The patch was left in
place for 1 week and then removed. At the end of the second week,
an identical patch was reapplied to the same skin site. Each mouse
had a total of three 1-week exposures to the patch, separated from
each other by 2-week intervals. Inspection confirmed that the patch
was still in place at the end of each sensitization period. Skin
biopsies from treated areas were obtained for RNA isolation and
histological evaluation. Six-micrometer thick skin sections were
stained with hematoxylin and eosin (H&E). Eosinophils were
counted under a microscope at a magnification of  400 and
expressed as the mean number of the cells in five random fields (one
section per mouse, five mice per group).
Northern blot analysis
Bone marrow cells were isolated from the femurs of MIF Tg or
WT mice, and 1 106 cellsml1 was collected. Total RNA was
isolated from bone marrow cells and skin from mice using an Isogen
RNA extraction kit according to the manufacturer’s protocols.
Twenty mg of RNA from control and test samples were loaded onto
a formaldehyde-agarose gel and the RNA was transferred onto a
nylon membrane. RNA fragments obtained by restriction
enzyme treatment for MIF and glyceraldehyde-3-phosphate
dehydrogenase were labeled with [a-32P]deoxycytidine triphosphate
using a DNA random primer labeling kit (Enzo Life Sciences
International, Farmingdale, NY). Hybridization was carried out at
42 1C for 24–48 hours. Post-hybridization washing was performed in
0.1% SDS with 0.2 standard saline citrate (1 standard saline
citrate: 0.15M NaCl, 0.015M sodium citrate) at 65 1C for
15minutes. The radioactive bands were visualized by autoradio-
graphy on Kodak X-AR5 film (Tokyo, Japan) and quantitatively
analyzed using the NIH Image system (Bethesda, MD). The results
were normalized by compensating for the glyceraldehyde-3-
phosphate dehydrogenase mRNA levels.
Reverse transcription-PCR analysis
Total RNA was extracted from each mouse skin specimen. RNA
reverse transcription was performed with M-MLV reverse transcrip-
tase using random hexamer primers and subsequent amplification
using Taq DNA polymerase. PCR was carried out for 35–40 cycles
with denaturation at 94 1C for 30 seconds, annealing from 46 to 64 1C
for 1minute and extension at 72 1C for 45 seconds using a thermal
cycler (PE Applied Biosystems Gene Amp PCR system 9700, Life
Technologies Japan, Tokyo, Japan). The primers used in this study are
described in Supplementary Table S1 online. After PCR, the amplified
products were analyzed by 2% agarose gel electrophoresis.
Western blot analysis
The epidermis of each mouse was homogenized with a Polytron
homogenizer (Kinematica, Lausanne, Switzerland). The protein
concentrations of the cell homogenates were quantified using a
Micro BCA protein assay reagent kit (Thermo Fisher Scientific,
Yokohama, Japan). Equal amounts of homogenates were dissolved in
20ml of Tris-HCL, 50mM (pH 6.8), containing 2-mercaptoethanol
(1%), SDS (2%), glycerol (20%) and bromophenol blue (0.04%),
and then were heated to 100 1C for 5minutes. The samples were then
subjected to SDS–PAGE and electrophoretically transferred onto a
nitrocellulose membrane. The membranes were blocked with 2.5%
non-fat dry milk powder in phosphate-buffered saline, probed with
antibodies against MIF (Shimizu et al., 1996) and subsequently
reacted with secondary IgG antibodies coupled with horseradish
peroxidase. The resultant complexes were processed for the ECL
detection system (Amersham Biosciences, Buckinghamshire, UK).
The relative amounts of proteins associated with specific antibodies
were normalized according to the intensities of b-actin (Sigma).
Cell culture
Skin specimens were obtained from the dorsal surfaces of newborn
MIF Tg, MIF KO, and WT mice. The skin specimens were cut into
3–5mm pieces and placed on a large Petri dish with the
subcutaneous side down, followed by tissue incubation for 1 week
in a humidified atmosphere of 5% CO2 at 37 1C. Once sufficient
numbers of fibroblasts had migrated out of the skin sections, pieces of
the skin were removed and the cells were passaged by trypsin
digestion in the same manner as wound-harvested fibroblasts.
Fibroblasts were grown in DMEM containing 10% fetal calf serum
and 1% penicillin/streptomycin. After 3 passages, the fibroblasts were
used for the experiments. The fibroblasts from MIF KO and WT mice
were stimulated with MIF (100ngml1), IL-4 (10ngml1), or MIF
(100 ngml1) in combination with IL-4 (10ngml1) for 24 hours. We
also stimulated the fibroblasts from MIF Tg, MIF KO, and WT mice
with IL-4 (5 or 10ngml1) alone for 24 hours. The cells were
analyzed using reverse transcriptase-PCR. Culture supernatants were
analyzed for eotaxin by ELISA.
Statistical analysis
Values are expressed as the means±SD of the respective test or
control group. The statistical significance of differences between the
control and test groups was evaluated by either Student’s t-test or
one-way analysis of variance.
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